Clinical Trials | March 03, 2026
Merck’s KEYTRUDA & WELIREG combo shows breakthrough results in kidney cancer trial
Merck emphasized the broader significance of the findings
Merck emphasized the broader significance of the findings
But acquisition charges drag earnings into loss
The current ruling will assure the safety of the use of Ranitidine for Indian patients
Researchers found that the drug combination led to a sustained and tenfold increase in the production of CD8 T cells and natural killer cells
Approximately five kg tumor was removed in the eight-hour long complicated surgery
Subscribe To Our Newsletter & Stay Updated
